IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $26,635,000 | +1007.5% | 313,242 | +361.7% | 0.01% | +900.0% |
Q2 2020 | $2,405,000 | +343.7% | 67,848 | +68.8% | 0.00% | – |
Q1 2020 | $542,000 | -85.2% | 40,201 | -76.8% | 0.00% | -100.0% |
Q4 2019 | $3,661,000 | -33.1% | 172,979 | -58.1% | 0.00% | -50.0% |
Q3 2019 | $5,472,000 | +70.7% | 412,661 | +78.6% | 0.00% | +100.0% |
Q2 2019 | $3,205,000 | +2464.0% | 231,022 | +3429.7% | 0.00% | – |
Q1 2019 | $125,000 | -92.2% | 6,545 | -94.2% | 0.00% | -100.0% |
Q4 2018 | $1,600,000 | +44.3% | 112,153 | +110.7% | 0.00% | – |
Q3 2018 | $1,109,000 | +395.1% | 53,226 | +463.2% | 0.00% | – |
Q2 2018 | $224,000 | -91.9% | 9,451 | -95.0% | 0.00% | -100.0% |
Q1 2018 | $2,765,000 | -52.5% | 189,230 | -47.4% | 0.00% | -50.0% |
Q4 2017 | $5,818,000 | +32.3% | 359,970 | +14.5% | 0.00% | 0.0% |
Q3 2017 | $4,397,000 | +609.2% | 314,475 | +348.2% | 0.00% | – |
Q2 2017 | $620,000 | +2483.3% | 70,164 | +1796.3% | 0.00% | – |
Q1 2017 | $24,000 | +140.0% | 3,700 | +37.0% | 0.00% | – |
Q4 2016 | $10,000 | +11.1% | 2,700 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | -83.9% | 2,700 | -88.7% | 0.00% | – |
Q2 2016 | $56,000 | +86.7% | 23,992 | +98.5% | 0.00% | – |
Q1 2016 | $30,000 | -85.1% | 12,089 | -81.6% | 0.00% | – |
Q4 2015 | $201,000 | +111.6% | 65,563 | +18.9% | 0.00% | – |
Q3 2015 | $95,000 | -64.4% | 55,150 | -16.2% | 0.00% | – |
Q2 2015 | $267,000 | +6.0% | 65,790 | 0.0% | 0.00% | – |
Q1 2015 | $252,000 | -44.0% | 65,790 | -29.8% | 0.00% | – |
Q4 2014 | $450,000 | – | 93,780 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |